Rosnani Nasution

Prof. Dr. Rosnani Nasution


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RYRika Yusnaini
Rika Yusnaini
RNRosnani Nasution
Rosnani Nasution
NSNurdin Saidi
Nurdin Saidi
TATeti Arabia
Teti Arabia
Rinaldi IdroesRinaldi Idroes
Rinaldi Idroes
Muhammad IqhrammullahMuhammad Iqhrammullah
Muhammad Iqhrammullah
A high prevalence of hyperuricemia among adult and older adult populations has intrigued the development of its therapy based on natural products. Our objective was to investigate the antihyperuricemic activity of the natural product from Limonia acidissima L. in vivo. The extract was obtained through the maceration of L. acidissima fruits using an ethanolic solvent and was tested for its antihyperuricemic activity against potassium oxonate-induced hyperuricemic rats. Serum uric acid, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and blood urea nitrogen (BUN) were observed before and after the treatment. Expression of urate transporter 1 (URAT1) was also measured using a quantitative polymerase chain reaction. Antioxidant activity based on a 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay, along with total phenolic content (TPC) and total flavonoid content (TFC), were measured. Herein, we present the evidence of the serum uric acid lowering effect of the L. acidissima fruit extract along with improved AST and ALT (p < 0.01). The reduction of serum uric acid was in accordance with the decreasing trend of URAT1 (1.02 ± 0.05-fold change in the 200 mg group), except in a group treated with 400 mg/kg body weight extract. At the same time, BUN increased significantly in the 400 mg group (from 17.60 ± 3.286 to 22.80 ± 3.564 mg/dL, p = 0.007), suggesting the renal toxicity of the concentration. The IC50 for DPPH inhibition was 0.14 ± 0.02 mg/L with TPC and TFC of 143.9 ± 5.24 mg GAE/g extract and 390.2 ± 3.66 mg QE/g extract, respectively. Further studies should be carried out to prove this correlation along with the safe concentration range of the extract.

9 May 2023 in Molecules
Verified
Journal Article
Open access
PDF file
IIIkhsan Ikhsan
Ikhsan Ikhsan
Rinaldi IdroesRinaldi Idroes
Rinaldi Idroes
AAAzharuddin Azharuddin
Azharuddin Azharuddin
RNRosnani Nasution
Rosnani Nasution
RYRika Yusnaini
Rika Yusnaini
Muhammad IqhrammullahMuhammad Iqhrammullah
Muhammad Iqhrammullah
An edible sea cucumber Holothuria atra has been hypothesized to have medicinal benefits against hyperuricemia owing to its bioactive compounds, including mono- and poly-unsaturated fatty acids. Herein, we aimed to investigate the fatty acids-rich extract produced from H. atra to treat hyperuricemic rats (Rattus novergicus). The extraction was carried out using n-hexane solvent and then administered to potassium oxonate-induced hyperuricemic rats, with allopurinol acting as a positive control. The extract (50, 100, 150 mg/kg body weight) and allopurinol (10 mg/kg) were administered QD through an oral route using a nasogastric tube. Serum uric acid, creatinine, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and blood urea nitrogen of the abdominal aortic blood were investigated. Our results suggested that the extract was rich in polyunsaturated (arachidonic acid) and monounsaturated fatty acids (oleic acid), in which its administration of 150 mg/kg could significantly reduce serum uric acid (p < 0.001), AST (p = 0.001), and ALT (p = 0.0302). The anti-hyperuricemic activity could be associated with the modulation of GLUT9 by the H. atra extract. In conclusion, the n-hexane extract from H. atra is a potential serum uric acid-lowering agent targeting GLUT9, where further investigations are crucially warranted.

14 November 2019 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
BABastian Arifin
Bastian Arifin
RNRosnani Nasution
Rosnani Nasution
NDNovi Desrianti
Novi Desrianti
MMMarianne Marianne
Marianne Marianne
HHHira Helwati
Hira Helwati
BACKGROUND: Aceh is a tropical region that is very many overgrown by various plants that have medicinal properties; one of them is M. elengi. M. elengi flower extract has the main content of triterpene and alcohol, that have antibacterial, antifungal, antioxidant and antineoplastic activity. Extraction of chemical compounds containing essential oils generally uses distillation, and get the small amounts of chemical compounds, while the maceration with n-hexane solvent, producing less active nonpolar compounds against S. aureus bacteria. AIM: Isolating the methanol extract from M. elengi flowers and test its antibacterial and antifungal activity. Furthermore, extracts with active concentrations are made into a lotion. METHODS: Methanol extract from M. elengi flower was characterised by gas chromatography-mass spectrometry, then tested for antibacterial and antifungal, then made into the lotion. The lotion was tested again for its antimicrobial activity, physical and organoleptic properties. RESULTS: The most abundant chemical compounds in an extract of M. elengi based on characterisation with GC-MS is Borneol L; (Bicyclo [2.2.1] heptane-2-ol, 1,7,7-trimethyl, as much as 82%). The methanol extract of M. elengi flower can inhibit the growth of S. aureus bacteria and C. albicans fungi, and also the lotion from methanol extract can inhibit the growth of S. aureus bacteria, but the M. elengi flower extract lotion cannot inhibit the growth of C. albicans fungi. The lotion inhibits the growth of S. aureus bacteria, from a concentration of methanol extract of 8% and 16%. Lotion with 16% methanol extract has 81.33% in activity power compared with positive control. The results of physical and organoleptic properties test, with the concentration of methanol extract of M. elengi 1, 2, 8, and 16%, have pH in the range of 6.6-8 (still in a safe range, 4.5-9 according to SNI 16-4399-1997). The lotion type is m/a, the spreading capacity of the lotion is 18.8 - 39.5 cm2. The power of adhesive at skin ranges from 1 minute 27 seconds to 3 minutes 7 seconds. The viscosity of the lotion ranges from 23,670-24,400 cP, this range is in the range based on SNI 16-4399-1996 (2000-50,000 cP), so the lotion is in a good category. The preferred lotion is at a concentration of 2%, in fragrance. CONCLUSION: Antibacterial activity of the lotion of methanol extract of M. elengi flower against S. aureus bacteria was the best at 16%, but could not inhibit the growth of C. albicans fungi. The most abundant compounds in methanol extract are Borneol L compounds; (Bicyclo [2.2.1] heptane-2-ol, 1,7,7-trimethyl. In general, the physical properties of this lotion meet the requirements of SNI16-4399-1996, SNI 16-4399-1997, and lotions which are preferred at a concentration of 2% in fragrance.

23 October 2016 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
RNRosnani Nasution
Rosnani Nasution
MYMustanir Yahya
Mustanir Yahya
MMMarianne Marianne
Marianne Marianne
IMIswani Marzuki
Iswani Marzuki
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.

1 March 2023 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
QQQuranayati Quranayati
Quranayati Quranayati
NSNurdin Saidi
Nurdin Saidi
NNNurliana Nurliana
Nurliana Nurliana
Rinaldi IdroesRinaldi Idroes
Rinaldi Idroes
NGNaufal Gusti
Naufal Gusti
RNRosnani Nasution
Rosnani Nasution
Context: Phyllanthus emblica stem barks are rich in antioxidants, but its utilization for antidiabetic and diabetic complications remains understudied. Aims: To evaluate the efficacy of extracts from P. emblica stem barks in improving diabetic nephropathy and hyperlipidemia in vivo. Methods: P. emblica stem bark powder was dried and macerated using n-hexane, ethyl acetate, and methanol simultaneously. The diabetic condition was induced by streptozotocin (STZ) in male Wistar rats. Treatment interventions included the oral administration of metformin (60 mg/kg body weight) or P. emblica stem bark extracts (200 mg/kg) once a day, where the fasting blood glucose (FBG) and total cholesterol levels were measured before and after the treatment. Results: Rats receiving the ethyl acetate extract exhibited a significantly lower FBG than the control (113.7 ± 15.04 versus 195 ± 19.97 mg/dL; p<0.05). Rats treated with ethyl acetate extract and methanol showed a significant decrease in total cholesterol levels with p-values of 0.037 and 0.004, respectively. Cellular damages observed on the histological images of the kidney were found to be significantly attenuated in all treated rats (p<0.001). Conclusions: P. emblica stem bark extracts are efficacious in treating diabetic complications, including nephropathy and hyperlipidemia.

6 September 2021 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PDF file
MMMarianne Marianne
Marianne Marianne
MMMariadi Mariadi
Mariadi Mariadi
SNSony Eka Nugraha
Sony Eka Nugraha
RNRosnani Nasution
Rosnani Nasution
PSPran Nando Syuhada
Pran Nando Syuhada
SPSylvia Pandiangan
Sylvia Pandiangan
Background: Curcuma heyneana (Valeton & Zijp.) or temu giring has various pharmacological activities. However, its hepatoprotective activity toward ethanol induction has never been carried out. Objectives: The objective of this research was to evaluate the hepatoprotective activity of the C. heyneana rhizome extract toward Wistar rats induced by ethanol. Methods: The research was initiated with the determination of curcuminoid content, total phenolic content, total flavonoid content, and characterization of extract using gas chromatography-mass spectrometry (GC-MS). Hepatoprotective activity was tested using the C. heyneana extract at doses of 50, 100, and 150 mg/kg with 5 g/kg ethanol as an inducer. Aspartate transaminase (AST), alanine transaminase (ALT), liver weight, and macroscopic and microscopic liver were used as parameters. Data were analyzed using analysis of variance (ANOVA). Results: The curcuminoid content of the extract was 1.18% (w/w). Total phenolic content of the C. heyneana extract was 400.37 mg gallic acid equivalent (GAE)/g sample, while total flavonoid content was 27.25 mg quercetin equivalent (QE)/g sample. Nine compounds were identified in the extract. Administration of the extract at doses of 50, 100, and 150 mg/kg kept the liver normal. It was identified macroscopically from the dark red color without any white spot and normal liver weight. Furthermore, at doses of 50, 100, and 150 mg/kg, the extract inhibited AST and ALT elevation, which was significantly different from the negative control group (P < 0.05). The extract also prevented hepatocyte injury that was seen microscopically. Conclusions: It can be concluded that the C. heyneana extract at doses of 50, 100, and 150 mg/kg is effective as hepatoprotective in the liver injury induced by ethanol.